Cargando…
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a “new” vaccine introduced in 1921, namely bacille Calmette-Guérin.
Autores principales: | Behr, Marcel A, Divangahi, Maziar, Schurr, Erwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798939/ https://www.ncbi.nlm.nih.gov/pubmed/33535239 http://dx.doi.org/10.1093/infdis/jiaa637 |
Ejemplares similares
-
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020) -
Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019
por: Ebina-Shibuya, Risa, et al.
Publicado: (2020) -
Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
por: Ehtesham, Nasreen Zafar, et al.
Publicado: (2020) -
Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011) -
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
por: Khanum, Iffat, et al.
Publicado: (2021)